Nirolex Tosse Secca (Dextromethorphan Hydrobromide)

Dextromethorphan, the active ingredient in Nirolex Tosse Secca, is a cough suppressant presented as an oral tablet for oral use. It is employed to alleviate dry and non‑productive coughs in adults and adolescents, helping to reduce the urge to cough without affecting normal respiratory function.

GNH USA supplies Nirolex Tosse Secca as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, including Europe, Asia and Africa.

Dextromethorphan acts as a central antitussive, reducing cough reflexes associated with dry or non‑productive coughs. - Dry cough: reduces frequency and intensity of coughing episodes. - Non‑productive cough: suppresses cough without clearing airway secretions. - Cough due to common cold: provides symptomatic relief of irritation‑driven cough.

Dextromethorphan may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: mild sedation or feeling of tiredness. - Nausea: upset stomach or urge to vomit. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Constipation: difficulty passing stool. - Mild headache: transient head discomfort.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperthermia, muscle rigidity when combined with serotonergic agents. - Hallucinations or psychotic symptoms: visual or auditory disturbances. - Severe respiratory depression: markedly reduced breathing effort. - Chest pain: unexplained thoracic discomfort.

When using Dextromethorphan, certain precautions should be observed to ensure safe and effective therapy. - Age restriction: avoid use in children under 4 years unless directed by a physician. - Concomitant MAO inhibitors: do not combine with monoamine oxidase inhibitors due to risk of severe reactions. - Alcohol and CNS depressants: limit intake as they may enhance sedative effects. - Liver impairment: use with caution and consider dose adjustment in patients with hepatic dysfunction. - Chronic respiratory disease: evaluate benefit‑risk in patients with asthma or COPD, as cough suppression may retain secretions. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Dextromethorphan can interact with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may cause hypertensive crisis or serotonin syndrome. - Serotonergic drugs (SSRIs, SNRIs, tramadol, linezolid): risk of serotonin syndrome. - Other NMDA antagonists: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Alcohol: may increase drowsiness and impair coordination. - CNS depressants (benzodiazepines, antihistamines): enhanced sedative effect. - Anticholinergic agents: may worsen dry mouth and constipation.